'As long ago as 2006, it was apparent that Genentech (then a partially owned Roche subsidiary) thought highly of this drug, which was obtained from a small biotech company called Tanox i'
actually there was a lot of heated arguments over this, with some people calling it junk ad others pushing strongly for it. the junk guys won for a while as there was already too much to take on with lucentis. i'm glad to see this alive and doing well